Allopurinol Tablet
Product Images NDC 43063-975

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Allopurinol (NDC 43063-975). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063975 Label (43063975)

Label for Allopurinol USP 100 mg tablets from PD-Rx Pharmaceuticals, Inc. The label specifies a 90-tablet count with NDC 43063-975-90 and includes dosage, storage warnings, and bilingual instructions for tablet use. Additional details include lot number C22F45 and expiration date 08/2023, with manufacturer information denoting Oklahoma City, OK.*

FDA Label Image

Structure (Allopurinol 01)

Chemical structure of Allopurinol, a human prescription drug with oral tablet dosage form. The image depicts the molecular structure typical of the Allopurinol compound.*

FDA Label Image

Figure (Allopurinol 02)

Chemical structure diagram depicting the conversion pathway among Allopurinol, Oxipurinol, Hypoxanthine, Xanthine, and Uric Acid molecules. It shows molecular structures and directional arrows illustrating biochemical transformations involving these compounds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.